Top 10 Continuous Glucose Monitors 2027

1. Dexcom G7

It ranks first because it pairs sub-9% MARD accuracy with the broadest automated-insulin-delivery interoperability of any sensor sold today. Dexcom's G7 sensor drives hybrid closed-loop therapy on Tandem and Insulet pump systems, which is the single most consequential compatibility in the category. Wear time is 10 days, factory-calibrated, so routine fingersticks drop to zero. Without insurance, monthly cost lands in the $75 to $300 band typical of mainstream systems.

This is the pick for anyone on an insulin pump, and for anyone who might move to one within a year. What it trades away is wear duration — 10 days means roughly 36 sensor changes a year versus 26 on a 14-day system, with a warm-up gap each time. Abbott's Libre line beats it on wear length and pharmacy access; Dexcom beats Abbott decisively on pump integration.

2. FreeStyle Libre 3

It ranks second on accuracy and form factor, sitting in the same sub-9% MARD tier as Dexcom while using one of the smallest sensors on the market. Wear runs 14 days factory-calibrated, meaning about 26 sensor changes a year instead of 36, with correspondingly fewer warm-up gaps and adhesive failures. Readings arrive roughly every minute rather than every five. Abbott's pharmacy distribution keeps acquisition simple and copays predictable.

This fits people managing diabetes without a pump, or with a pump system Abbott supports. What it gives up is the deep third-party closed-loop interoperability Dexcom has built with Tandem and Insulet — historically Libre's weakest axis, and the reason it dominates the non-pump market instead. Against the G7 above, choose Libre if wear duration and cost matter more than pump algorithm compatibility.

3. Dexcom G6

It ranks third as the proven, widely covered predecessor still supported across a large installed base of pumps and clinic workflows. The G6 is factory-calibrated with a 10-day sensor and a separate reusable transmitter, and its pump interoperability with Tandem and Insulet systems is the most battle-tested in the field. Formulary coverage is broad because payers have priced this system for years. Replacement policies for early sensor failure are well established.

This is for people whose pump firmware is validated against G6 specifically, or whose plan covers G6 at a lower copay than G7. The trade is a bulkier two-piece design and transmitter amortization the one-piece G7 above eliminates. Confirm your exact pump model and firmware version with the manufacturer before committing, because compatibility is version-specific.

4. FreeStyle Libre 2

It ranks fourth on value: 14-day factory-calibrated wear with optional real-time alarms, at some of the lowest landed monthly cost in the category. It reads in the same 8 to 10% MARD band as pricier systems, which matters because the practical difference between 8.1% and 8.7% is smaller than the variance from sensor placement and day-one hydration. Pharmacy availability keeps the acquisition path short.

This suits cost-sensitive users and type 2 patients not on insulin, where the A1C effect is smaller but time-in-range and hypoglycemia awareness still improve. It trades away the smaller footprint and one-minute refresh of Libre 3 above, and it sits outside the third-party closed-loop ecosystem entirely. If budget is the binding constraint rather than pump integration, this is the efficient choice.

5. Dexcom Stelo

It ranks fifth because it is the over-the-counter entry point — no prescription, no endocrinology visit, bought directly at a pharmacy counter. Stelo is built for people with type 2 diabetes who are not using insulin, and for that population the relevant metrics are time-in-range and pattern visibility rather than dosing precision. Factory-calibrated, so zero fingersticks for routine use. The OTC funnel changes total landed cost meaningfully.

This is for the curious consumer or newly diagnosed type 2 patient who wants feedback on how specific meals and walks move glucose. What it deliberately omits is urgent-low alerting and insulin-dosing indication, which is why insulin users must look higher on this list. Against Libre 2 above, Stelo wins on access simplicity and loses on established insurance coverage.

6. Abbott Lingo

It ranks sixth as Abbott's over-the-counter consumer sensor, aimed at people without diabetes who want to see how meals, sleep, and training load move their glucose. It is sold without a prescription and priced as a wellness subscription rather than a medical claim. The underlying sensing hardware descends from the Libre platform, so the data quality sits in the same general band as Abbott's clinical products. Wear runs 14 days.

This is for the metabolically curious, not for anyone dosing insulin. The honest trade is that the evidence base for health outcomes in non-diabetic users is thinner than the marketing implies, and misinterpretation is a real risk without professional guidance. Compared to Stelo above, Lingo targets non-diabetic users specifically while Stelo is indicated for non-insulin type 2 diabetes.

7. Medtronic Guardian 4

It ranks seventh because it is mandatory rather than optional: Medtronic sensors drive Medtronic MiniMed pumps, and no other sensor does. If you are running a MiniMed system with automated insulin delivery, the pump chooses the sensor and the decision is already made. Guardian 4 removes the routine fingerstick calibration burden that earlier Guardian generations required, which is a meaningful adherence change over 365 days.

This is for MiniMed pump users, full stop. What it trades away is choice — you cannot mix a Medtronic pump with a Dexcom sensor, so the ecosystem lock is total. Reported accuracy has historically trailed the Dexcom and Abbott sensors ranked above it, which is why it sits here despite being non-negotiable for its own user base. Evaluate at the system level, not the sensor level.

8. Eversense E3

It ranks eighth for inverting the wear model entirely: a clinician implants a subcutaneous sensor that runs up to roughly six months, with a removable rechargeable transmitter worn on the skin above it. That eliminates the adhesive-failure and sensor-change ritual that drives most day-to-day CGM frustration. The transmitter can come off for a shower or a swim without wasting a sensor. Insertion and removal are in-office procedures.

This fits people with adhesive sensitivity, frequent sensor failures, or a strong preference against a visible disposable patch every two weeks. The trades are real: calibration fingersticks, two clinic visits per sensor cycle, and no third-party closed-loop pump integration of the kind Dexcom offers. Against the Medtronic system above, Eversense wins on wear duration and loses on pump interoperability.

9. Eversense 365

It ranks ninth as the longest-wear option available — a single implanted sensor rated for about a year, roughly double the E3 cycle and covering the whole calendar with one insertion and one removal. For anyone who counts sensor changes as the primary burden, going from 26 disposable applications a year to one clinic-placed sensor is the largest single reduction in ritual any system offers. The transmitter recharges and detaches.

This is for established users who already know the implantable model works for them and want to cut clinic visits in half versus E3. The trades carry over: calibration burden, a required procedure, and no automated insulin delivery integration. It sits below E3 only because the shorter cycle gives newcomers a lower-commitment way to find out whether an implant suits them at all.

10. FreeStyle Libre Pro

It ranks tenth because it serves a narrow but real purpose: it is a professional, blinded sensor that a clinic applies and the patient cannot see. Data is downloaded at the follow-up visit, producing an unobserved baseline glucose record over the wear period. Removing the display removes the behavior change that a visible CGM causes, which is exactly the point when a clinician needs an honest picture of typical days.

This is a clinic tool, not a consumer purchase, and it belongs at the bottom of a consumer ranking for that reason. It trades away the entire real-time value proposition — no arrows, no alerts, no closing the feedback loop between action and glucose. Every system ranked above it exists to give the patient that loop; this one exists to take it away deliberately, for diagnosis.

How we ranked these

Ranking weighted four axes. Accuracy carried the most weight, anchored on published MARD — under 9% scored well, with low-range accuracy weighted above overall average. Insulin-pump interoperability came second, since a pump algorithm reading the sensor stream directly is a hard constraint, not a preference. Calibration burden counted third: factory-calibrated systems requiring zero fingersticks beat systems demanding two daily lancet events. Wear duration and total twelve-month landed cost, including transmitter amortization, closed the scoring.

Deliberately ignored: MARD differences under roughly half a percentage point, because the gap between 8.1% and 8.7% is smaller than the variance introduced by sensor placement and day-one hydration. Also ignored were app cosmetics, social-sharing features, and non-diabetic wellness marketing claims, where the outcome evidence is thinner than the promotion suggests. Sticker price per sensor was excluded as a unit — only monthly landed cost counted.

What to look for

Start with the pump question, because it collapses the decision. If you use automated insulin delivery, the pump algorithm must read the sensor stream directly, so the pump chooses the sensor and everything else is secondary — confirm the specific pump model and firmware, since compatibility is version-specific. If you are not on a pump, optimize for monthly cost, formulary coverage, and app quality instead, and over-the-counter availability meaningfully changes your acquisition path.

The common mistake is shopping MARD decimal points. Buyers compare 8.1% against 8.7% as though it were decisive, then ignore the physiological lag every sensor shares: interstitial fluid trails blood by roughly five to fifteen minutes, and that gap widens during rapid change. The second mistake is computing sticker price per sensor rather than twelve-month cost including transmitters, then discovering the formulary status afterward.

Related questions

Do I need a prescription for a CGM?

Not always. Over-the-counter continuous glucose monitors are now sold in the United States directly at pharmacies for people not using insulin. Prescription pathways still apply for insulin-using patients and for systems that integrate with pumps, and insurance coverage generally requires one. The over-the-counter route changes the acquisition funnel considerably — no endocrinology visit required before you start wearing one.

Can a CGM replace fingersticks entirely?

For most factory-calibrated systems, yes, for routine decisions. Confirm with a fingerstick when the reading contradicts how you feel, during a suspected compression low, or when symptoms and numbers disagree. Keep a working meter and in-date strips regardless of which system you wear, because sensor failures and disagreements both happen and you need a fallback that does not depend on the sensor.

Does a CGM help people without diabetes?

It can build genuine awareness of how specific meals and activity move your glucose. But the evidence base for health outcomes in non-diabetic users is thinner than the marketing implies, and misinterpretation is a real risk — normal glucose excursions get read as problems. Pair it with professional guidance rather than treating every post-meal rise as something requiring correction.

How accurate are CGMs during exercise?

Less accurate than at rest. Rapid glucose change plus exercise-driven fluid shifts widen the gap between interstitial and blood glucose, which is where the five-to-fifteen-minute lag hurts most. Read the trend arrow rather than the absolute number during hard efforts, and confirm with a fingerstick before treating a suspected low. If you are dropping fast, the sensor number is optimistic.

What happens if a sensor fails early?

Most manufacturers replace sensors that fail before their labeled wear time, typically through a support request citing the sensor's lot and serial number. Policies vary meaningfully between vendors on how many replacements they will issue and how quickly. Check the terms before you buy rather than after a failure, because replacement generosity is a real part of total cost.

How much A1C improvement should I expect?

Clinical literature in type 1 diabetes consistently shows roughly 0.3 to 0.6 percentage points versus fingerstick-only monitoring, with the largest gains among people who previously tested infrequently. In type 2 diabetes, particularly among people not on insulin, the effect is smaller and noisier — but time-in-range and hypoglycemia-awareness metrics still move meaningfully even when A1C barely does.

What is a compression low?

A falsely low reading caused by lying on the sensor, which restricts local interstitial fluid flow and depresses the measured value. It typically appears overnight, drops fast, and resolves once you shift position. It is one of the clearest cases for confirming with a fingerstick before treating, since eating to correct a compression artifact produces a real rebound high.

Why does the sensor lag my meter?

Every CGM measures interstitial fluid rather than blood, which introduces a physiological lag of roughly five to fifteen minutes. That gap widens whenever glucose moves fast — after a high-carb meal, during exercise, or mid-correction. Spiking fast makes the sensor conservative; dropping fast makes it optimistic. Experienced users learn to read the arrow more than the number in those windows.

FAQ

What is MARD and why does it matter?

MARD, or Mean Absolute Relative Difference, expresses the average percentage gap between a sensor's readings and a laboratory reference. Lower is better, and consumer systems generally sit between 8% and 10%. It is the best single accuracy summary available, but it averages across glucose ranges — accuracy in the low range matters more clinically, so ask for that figure specifically rather than the headline number.

How long do sensors last?

Mainstream wear times run roughly 10 to 15 days per sensor. Implantable systems from Senseonics extend far longer, up to about a year, at the cost of requiring a clinician to insert and remove them. Always follow the labeled wear time rather than trying to stretch it — longer wear also means fewer warm-up gaps and fewer adhesive failures.

Do I still need fingersticks?

Most current systems are factory-calibrated and need none for routine use. Implantable and professional or blinded clinic systems may still require daily calibration. Two fingersticks a day sounds trivial in the abstract but amounts to roughly 730 lancet events a year, which is a real adherence tax. Regardless of system, keep a meter for confirming readings that contradict your symptoms.

Can I swim or shower with a sensor on?

Generally yes. Mainstream sensors carry water-resistance ratings covering showering and swimming at shallow depth for limited durations. Check the specific rating for your model. If you swim regularly, consider an overpatch — adhesive failure is far more common than actual water ingress, and a sensor that peels off mid-wear costs you the same as one that floods.

Which CGM works with my insulin pump?

Pump compatibility is the strongest constraint in the entire decision. Dexcom sensors interoperate with Tandem and Insulet systems; Medtronic sensors drive Medtronic MiniMed pumps. Abbott's Libre line has historically been weakest here, which is why it dominates the non-pump market instead. Confirm your specific pump model and firmware with the manufacturer — compatibility is version-specific and changes across releases.

How much does a CGM cost each month?

Without insurance, expect roughly $75 to $300 per month depending on system and region. With coverage, it is typically a pharmacy copay. Calculate on a twelve-month basis including any transmitter costs rather than comparing sticker price per sensor, and confirm your plan's formulary status before committing to a brand — coverage often matters more than list price.

How many readings does a CGM actually produce?

A reading roughly every five minutes, which works out to between 250 and 300 data points every 24 hours, replacing four to eight daily fingersticks. That density is the whole value proposition. A fingerstick gives you a number; a CGM gives you a direction, a slope, and a history — which is what makes pattern visibility possible at all.

Should I pair a CGM with a smart insulin pen?

If you inject, yes. Smart pens log dose and timing automatically, closing the other half of the feedback loop. Without dose data a glucose curve tells you what happened but not why; pairing the two turns a chart into a causal record. Third-party analytics platforms can aggregate both streams if your devices come from different manufacturers.

How should I structure my first twelve weeks?

Wear baseline for two weeks changing nothing, just observing. Weeks three and four, test single variables — meal order, a post-meal walk, sleep timing. Weeks five through eight, review with a clinician: tune basal and ratios if you use insulin, revisit timing and diet structure if you do not. At week twelve, evaluate time in range and reassess.

Do I need continuous ketone monitoring too?

It matters most for people at risk of diabetic ketoacidosis, particularly pump users — a pump occlusion can produce rising glucose and rising ketones simultaneously, and glucose alone will not tell you which is happening. Continuous ketone sensing has been an active development area worth watching. For now, keep ketone strips available if you are on a pump.

Sources

• https://www.fda.gov/medical-devices/consumer-products/continuous-glucose-monitors
• https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/continuous-glucose-monitoring
• https://diabetesjournals.org/care
• https://www.dexcom.com
• https://www.freestyle.abbott
• https://www.medtronic.com/us-en/patients/treatments-therapies/diabetes.html
• https://www.eversensediabetes.com
• https://www.cdc.gov/diabetes
• https://www.breakthrought1d.org

Related on PULSE

• [More continuous glucose monitors 2027 rankings and buying guides](/knowledge)
• [PULSE Tools and calculators](/tools)
• [Everything on PULSE RevOps](/)